Loading…
Vera Therapeutics, Inc. is projected to rise to $56.15 by 2027, a +40% move from its current price of $40.03. VERA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $38.89 | $40.02 | $41.19 | -0.01% |
| Jul 13 | $38.43 | $40.02 | $41.68 | -0.01% |
| Jul 14 | $38.08 | $40.02 | $42.06 | -0.02% |
| Jul 15 | $37.78 | $40.02 | $42.38 | -0.02% |
| Jul 16 | $37.52 | $40.01 | $42.67 | -0.03% |
| Jul 17 | $37.29 | $40.01 | $42.93 | -0.03% |
| Jul 18 | $37.08 | $40.01 | $43.17 | -0.04% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $37.08 | $40.01 | $43.17 | -0.04% |
| Week 2 | $35.92 | $40.00 | $44.53 | -0.07% |
| Week 3 | $35.05 | $39.98 | $45.61 | -0.11% |
| Week 4 | $34.33 | $39.97 | $46.53 | -0.15% |
| Week 5 | $33.71 | $39.95 | $47.35 | -0.18% |
| Week 6 | $33.15 | $39.94 | $48.11 | -0.22% |
| Week 7 | $32.65 | $39.92 | $48.82 | -0.26% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Vera Therapeutics, Inc. is a clinical stage biotechnology company focused on the development and commercialization of transformative treatments for patients with immunological diseases. The company offers atacicept, a fully humanized TACI-Fc fusion protein that binds B-cell activating factor (BAFF) and A proliferation-inducing ligand (APRIL), which is self-administered at home as a subcutaneous injection being evaluated for the treatment of immunoglobulin A nephropathy (IgAN) and other autoimmune kidney diseases.
It is also developing MAU868, a human monoclonal antibody for the treatment of BK viremia infections that has completed phase 2 clinical trial; and VT-109, a novel BAFF/APRIL dual-inhibitor B cell maturation antigen (BCMA) molecule to treat B cell mediated autoimmune diseases. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc.
in April 2020.
Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.
Vera Therapeutics, Inc. trades under the ticker VERA. The current price is $42.46 and the asset has a market capitalization of $3.05B, ranked 1735.
The price outlook from the available forecast points to a bullish path over the longer horizon, with rising average prices across successive years. The forecast for 2026 shows an average price of $42.46, with 2027 at $59.21 and a continued upward trajectory into 2030, 2040, and 2050.
Key forecast anchors include 2026 avg $42.46, 2027 avg $59.21, 2030 avg $70.23, 2040 avg $172.66, and 2050 avg $307.50, accompanied by positive sentiment and rising ROI figures through 2050.
A major floor 32.8% below — a decisive break under it would weaken the trend.
The nearest floor, 21.9% below — buyers have tended to step in here.
The nearest ceiling, 7.8% above — a clean break opens room to run.
A major ceiling 26.7% above — clearing it would confirm fresh momentum.
Key VERA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of VERA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $41.99 | Sell | $42.10 | Sell |
| MA 10 | $42.24 | Sell | $41.46 | Sell |
| MA 20 | $39.25 | Buy | $39.83 | Buy |
| MA 50 | $36.55 | Buy | $38.27 | Buy |
| MA 100 | $38.62 | Buy | $38.26 | Buy |
| MA 200 | $38.35 | Buy | $37.13 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 61.77 | Neutral |
| Stoch RSI (14) | 20.06 | Neutral |
| CCI (20) | 58.46 | Neutral |
| Williams %R (14) | -23.23 | Info |
| MACD (12,26,9) | 0.22 | Buy |
| ROC (12) | 9.95 | Buy |
| Bollinger %B (20,2) | 0.70 | Neutral |
| Stochastic %K (14) | 76.77 | Neutral |
| TRIX (15) | 0.71 | Buy |
| Awesome (5,34) | 5.21 | Buy |
| Ultimate (7,14,28) | 54.13 | Neutral |
| Momentum (10) | 1.50 | Buy |
| Aroon Osc (25) | 68.00 | Buy |
| Hull MA (9) | 42.41 | Sell |
| ADX (14) | 25.91 | Buy |
| ATR (14) | 0.95 | Info |
In the near term, sentiment is bullish with RSI(14) at 70 and moving averages hovering above the recent price.
The 50-day simple moving average is $36.11 and the 200-day simple moving average is $37.49, signaling a positive tilt versus the price. Support is cited at $31.26 and resistance at $40.50, framing a constructive short-term backdrop.
The 30-day range runs from $34.50 up to $52.26, and annualized volatility is around 60%, indicating substantial price movement potential within the month.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $31.26 | $40.03 | $51.25 | 0% | Neutral | |
| $44.48 | $56.15 | $75.11 | +40% | Bullish | |
| $45.39 | $59.00 | $82.04 | +47% | Bullish | |
| $46.82 | $62.38 | $89.38 | +56% | Bullish | |
| $50.84 | $69.22 | $101.74 | +73% | Bullish | |
| $50.28 | $69.83 | $104.92 | +74% | Bullish | |
| $60.35 | $85.37 | $130.84 | +113% | Bullish | |
| $71.28 | $102.59 | $160.07 | +156% | Bullish | |
| $72.86 | $106.59 | $169.08 | +166% | Bullish | |
| $79.69 | $118.43 | $190.76 | +196% | Bullish | |
| $113.40 | $181.08 | $310.92 | +352% | Bullish | |
| $178.56 | $322.83 | $608.32 | +707% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $31.26 | $40.03 | $47.00 | +0.00% |
| August 2026 | $32.79 | $38.76 | $47.10 | -3.15% |
| September 2026 | $33.45 | $39.84 | $48.97 | +2.76% |
| October 2026 | $33.49 | $40.13 | $49.82 | +0.75% |
| November 2026 | $32.73 | $39.44 | $49.36 | -1.73% |
| December 2026 | $33.56 | $40.64 | $51.25 | +3.05% |
Click any year to see its month-by-month VERA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The VERA price prediction for 2026 points to an average of $40.03 (low $31.26, high $51.25) — a potential gain of 0% on today's $40.03. A consolidation phase looks the most probable path here.
In 2027, VERA is projected to trade between $44.48 and $75.11, averaging $56.15 — a potential gain of +40% from today's $40.03. That is up +40% on the projected 2026 average. Momentum favours further upside here.
Vera Therapeutics, Inc.'s 2028 outlook centres on $59.00, within a $45.39 to $82.04 range. That is up +5% on the projected 2027 average. That marks a +47% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, VERA could reach as high as $89.38, with a base case around $62.38 and support toward $46.82 — roughly +56% from $40.03. Momentum favours further upside here.
Expect VERA to range from $50.84 to $101.74 through 2030. The $69.22 average target implies a +73% move from current prices. That is up +11% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The VERA price prediction for 2031 points to an average of $69.83 (low $50.28, high $104.92) — a potential gain of +74% on today's $40.03. Momentum favours further upside here.
In 2032, VERA is projected to trade between $60.35 and $130.84, averaging $85.37 — a potential gain of +113% from today's $40.03. That is up +22% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Vera Therapeutics, Inc.'s 2033 outlook centres on $102.59, within a $71.28 to $160.07 range. That is up +20% on the projected 2032 average. That marks a +156% change versus current levels. Momentum favours further upside here.
By 2034, VERA could reach as high as $169.08, with a base case around $106.59 and support toward $72.86 — roughly +166% from $40.03. Buyers look set to stay in control over this stretch.
Expect VERA to range from $79.69 to $190.76 through 2035. The $118.43 average target implies a +196% move from current prices. That is up +11% on the projected 2034 average. Momentum favours further upside here.
The VERA price prediction for 2040 points to an average of $181.08 (low $113.40, high $310.92) — a potential gain of +352% on today's $40.03. Buyers look set to stay in control over this stretch.
In 2050, VERA is projected to trade between $178.56 and $608.32, averaging $322.83 — a potential gain of +707% from today's $40.03. That is up +78% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in VERA today (≈ 24.984385 VERA) could be worth
$8,065.71
+$7,065.71 (+707%) by 2050 · US Dollar
Based on the average projected VERA price of $322.83 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in VERAwould be worth at today's price.
$1,000 invested in VERA on Jul 10, 2025 (≈ 41.067761 VERA) would be worth
$1,643.74
+$643.74 (+64.4%) today · 1.64× · US Dollar
Based on a VERA entry price of $24.35 vs. today's $40.03.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $41.2 | $971.48 | -2.9% |
| 1 month ago | $31.62 | $1,265.81 | +26.6% |
| 3 months ago | $45.04 | $888.65 | -11.1% |
| 6 months ago | $46.46 | $861.49 | -13.9% |
| 1 year ago | $24.35 | $1,643.74 | +64.4% |
| All time (5.0y) ago | $14.89 | $2,688.05 | +168.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our VERA forecast.
Our base-case forecast reaches $80.00 around 2032.
Implied market cap at $80.00: $5.74B
The multi-year forecast paints a bullish trajectory, with an expanding average price and meaningful upside into the late 2020s and beyond.
For 2030, the forecast shows an average of $70.23 with a min of $50.62 and a max of $105.44, reflecting a 65.4 level of implied return. The 2040 target carries an average of $172.66 and a max of $305.94, with a 306.6 implied return, while 2050 projects an average of $307.50 and a max of $601.24, with a 624.2 implied return.
From 2027 onward, the forecast is consistently bullish, with 2027 avg $59.21 and 2028 avg $60.99, progressing to higher price levels and substantial upside by 2050. These figures illustrate potential gains but are estimates only and carry inherent uncertainty and risk.
Tap a question to reveal the answer.
The 2030 forecast shows a min of $50.62, an average of $70.23, and a max of $105.44, with a 65.4 ROI and bullish sentiment.
The forecast landscape shows bullish sentiment across multiple years, with increasing average prices (e.g., $59.21 in 2027, $70.23 in 2030, $172.66 in 2040, and $307.50 in 2050). However, these are estimates and not guarantees.
Yes, the 2030 max is $105.44, and the 2031 max is $106.30, with higher maxes in later years (e.g., 2032 $134.37, 2033 $162.84).
The current price is $42.46.
Market cap is $3.05B and the rank is 1735.
Vera Therapeutics, Inc. Community Discussion
0Share your Vera Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.